Showing posts with label #Global_exposure_of_your_research_at_Chronic_Diseases_Congress_2018_Tokyo #Alzheimer's_Disease #Dementia. Show all posts
Showing posts with label #Global_exposure_of_your_research_at_Chronic_Diseases_Congress_2018_Tokyo #Alzheimer's_Disease #Dementia. Show all posts

Wednesday, 29 August 2018

Track 16: #Alzheimer's_Disease



Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time.  It is the cause of 60–70% of cases of dementia. The most common early symptom is difficulty in remembering recent events (short-term memory loss). As the disease advances, symptoms can include problems with language, disorientation (including easily getting lost), mood swings, loss of motivation, not managing self-care, and behavioural issues. As a person's condition declines, they often withdraw from family and society. Gradually, bodily functions are lost, ultimately leading to death. Although the speed of progression can vary, the typical life expectancy following diagnosis is three to nine years

Facts on Alzheimer's disease

Alzheimer's disease is the most common type of dementia.
It happens when plaques containing beta-amyloid form in the brain.
As symptoms worsen, it becomes harder for people to remember recent events, to reason, and to recognize people they know.

Eventually, a person with Alzheimer's is likely to need full-time assistance

Global exposure of your research on Alzheimer's disease

Website: